Status:

UNKNOWN

Moleculight i:X™ in Wound Healing

Lead Sponsor:

The Leeds Teaching Hospitals NHS Trust

Conditions:

Ulcer Foot

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

Diabetic foot disease is a global health problem. Diabetes affects over 450million people worldwide, expected to rise to 1 in 10 people by 2040. 60-70% will lose sensation in their feet and up to 25% ...

Eligibility Criteria

Inclusion

  • Aged ≥ 18 years
  • Diagnosis of Diabetes (according to WHO criteria)
  • Has ulceration of the foot below the malleoli
  • Expected to comply with the treatment strategies and follow up schedule
  • Consent to foot and wound photography
  • Consent to participate (written/witnessed verbal consent)

Exclusion

  • Has any current clinically infected diabetic foot ulcer (as per IDSA guidelines).
  • Estimated glomerular filtration rate (eGFR) \<20mL/min/1.73m2 (measurements taken within 3 months of randomisation can be used if no change in intervention or vascular events have occurred)
  • Has ABPI \<0.5 or opening toe pressure \<30mmHg (measured within 3 months of randomisation)
  • Planned or previous treatment with corticosteroids to an equivalent dose of Prednisolone \>10mg per day or other immunosuppressive therapy within 4 weeks prior to randomisation
  • Has evidence of connective tissue disorders (e.g. vasculitis or rheumatoid arthritis) and has planned or is under active treatment.
  • Has evidence of dermatological disorders (e.g. pyoderma gangrenosum or epidermolysis bullosa)
  • Has previously been randomised to the Moleculight i:X™ study
  • Lacks mental capacity and is unable to provide informed consent.

Key Trial Info

Start Date :

December 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2018

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03270904

Start Date

December 1 2017

End Date

August 31 2018

Last Update

January 24 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Leeds Teaching Hospitals NHS Trust

Leeds, United Kingdom